Bio-Techne Newsroom

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

PR NewswireDec 20 20:00

Bio-Techne, Waters Strike Co-Marketing, Co-Promotion Deal

MT NewswiresDec 19 23:15

Express News | Bio-Techne Announces Biotherapeutic Characterization Strategic Co-Marketing and Co-Promotion Agreement

BreakingsDec 19 20:00

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

PR NewswireDec 19 20:00

Press Release: ScaleReady Awards a G-Rex(R) Grant to Moonlight Bio

Dow JonesDec 18 20:00

What You Can Learn From Bio-Techne Corporation's (NASDAQ:TECH) P/S

Simply Wall StDec 13 20:28

Bio-Techne and MedSanTek Team Up to Boost Research in Turkey and Azerbaijan

BenzingaDec 12 20:09

Express News | Bio-Techne Announces New Distribution Agreement With Medsantek to Expand Access to Portfolio Across Turkey

BreakingsDec 12 20:00

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY

PR NewswireDec 12 20:00

S&P 500 Futures Rise In Premarket Trading; Bausch + Lomb, Bio-Techne Lag

Dow JonesDec 11 20:30

RBC Capital Sticks to Their Hold Rating for Bio-Techne (TECH)

TipRanksDec 11 09:45 · Ratings

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY

PR NewswireDec 10 20:00

BioCytics Awarded a G-Rex Grant From ScaleReady

PR NewswireDec 4 01:23

Gene Editing Market Forecast Report 2024, With Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More

Yahoo FinanceNov 29 17:43

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE

PR NewswireNov 27 20:00

Express News | Gemini Bioproducts: Transition of FBS Products to Geminibio Effective December 3, 2024

BreakingsNov 25 22:04

Express News | Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory From Bio-Techne

BreakingsNov 25 22:02

Press Release: Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory From Bio-Techne

Dow JonesNov 25 22:02

OverT Bio Receives $120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements

BusinesswireNov 22 22:00

Are Bio-Techne Corporation's (NASDAQ:TECH) Mixed Financials Driving The Negative Sentiment?

Simply Wall StNov 22 19:58